SERPINE1 and metabolic syndrome: Therefore, the purpose of the present research was to assess the PAI-1 plasma concentrations among subjects with T2DM aggravated by the Metabolic Syndrome before clinical manifestations of atherothrombotic disease in addition to evaluating the contribution of metabolic factors and the 4G/5G polymorphism of the PAI-1 gene on the plasma variability of PAI-1 among a sample of Mexican subjects with T2DM plus the Metabolic Syndrome.